FDA Approves Pfizer Cancer Treatment

January 27, 2012, 7:29 am by Wall Street Journal

U.S. regulators approved Pfizer's Inlyta drug for treating advanced kidney cancer, the latest of several drugs to be approved for the disease in recent years.

Read the full article

More from Wall Street Journal

Panel Backs Weight-Loss Drug Qnexa
Wall Street Journal : February 22, 2012, 5:10 am
An FDA panel backed Vivus's Qnexa, which could lead to approval of the first new prescription weight-loss drug in more than a decade.

More Suppliers Linked to Heparin Contamination
Wall Street Journal : February 22, 2012, 4:58 am
The FDA found 14 additional Chinese companies were supplying contaminated raw material to make heparin, a widely used blood thinner.

FDA to Boost Supply of Cancer Drugs
Wall Street Journal : February 21, 2012, 11:49 am
The FDA approved two new suppliers of two cancer drugs that are currently in short supply.

Justices Reject J&J Bid to Save Patent Case
Wall Street Journal : February 21, 2012, 10:58 am
The U.S. Supreme Court refused to consider a J&J subsidiary's bid to save its patent lawsuit targeting Abbott Laboratories' treatment for rheumatoid arthritis.

J&J CEO Weldon Is Out
Wall Street Journal : February 21, 2012, 10:19 am
Johnson & Johnson picked Alex Gorsky to be its next chief executive. He will take over from longtime leader William Weldon in April.